Clinical Trial Update: Proteomic Profiling to Differentiate Pancreatic and Biliary Adenocarcinomas

View source ↗

Summary

This clinical trial update outlines a study using proteomic profiling to differentiate pancreatic adenocarcinoma from biliary adenocarcinomas (cholangiocarcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Pancreatic Adenocarcinoma

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Pancreatic Adenocarcinoma | Status: NOT_YET_RECRUITING